Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrugDate fromSubject ▲
 16.5.2019B.Braun Melsungen AG (BME)05626NuTRIflex Omega plus (emu inf 5x1250 ml (vak.PA/PP - viackomor.))16.5.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)80020Irbesartan Actavis 300 mg (tbl flm 60x300 mg (fľ.HDPE))15.12.2019Z
 2.5.2019Sandoz Pharmaceuticals d.d. (SAN-SLO-1)36467Vinorelbin "Ebewe" 10 mg/ ml infúzny koncentrát (con inf 1x5 ml/50 mg (liek.inj.skl.))15.5.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)80016Irbesartan Actavis 300 mg (tbl flm 84x300 mg (blis.PVC/PVDC/Al))1.10.2019Z
 14.6.2019medac Gesellschaft für klinische Spezialpräparate m.b.H. (MED-2)86630Temomedac 20 mg tvrdé kapsuly (cps dur 5x20 mg (fľa.skl.))15.8.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)79737Irbesartan Actavis 150 mg (tbl flm 28x150 mg (blis.PVC/PVDC/Al))25.4.2019Z
 13.5.2019Egis Pharmaceuticals PLC (EGI)84648Hotemin 10 mg/g krém (crm der 1x50 g/0,5 g (tuba Al))1.7.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)80003Irbesartan Actavis 150 mg (tbl flm 84x150 mg (blis.PVC/PVDC/Al))24.1.2019Z
 28.5.2019Taw Pharma (Ireland) Limited (TWP)78708Clopidogrel Taw Pharma 75 mg filmom obalené tablety (tbl flm 90x75 mg (blister OPA/Al/PVC/Al))30.6.2019Z
 28.5.2019Mylan Ireland Limited (MNY)6248AIrbesartan/Hydrochlorothiazid Mylan 300 mg/25 mg (tbl 28x300 mg/25 mg (blis.Amber/Aclar/PVC/Al))30.6.2019Z
 28.5.2019Mylan Ireland Limited (MNY)8817BAmoxicillin/Clavulanic Acid Mylan 500 mg/125 mg filmom obalené tablety (tbl flm 21x500 mg/125 mg (blis.OPA/Al/PVC/Al))30.6.2019Z
 18.4.2019Actavis Group PTC ehf. (ACT-5)80013Irbesartan Actavis 300 mg (tbl flm 28x300 mg (blis.PVC/PVDC/Al))25.4.2019Z
 21.5.2019Actavis Group PTC ehf. (ACT-5)4162BCodamol 500 mg/30 mg (tbl flm 10x500 mg/30 mg (blis.PVC/Al))31.7.2019Z
 10.5.2019CANDE s.r.o. (CRR-SK)1965BSTALEMED 50 mg/12,5 mg/200 mg (tbl flm 100x50 mg/12,5 mg/200 mg (fľ.HDPE))29.6.2019Z
 5.6.2019Corza Medical GmbH (CRZ)2309BTachoSil matrica s tkanivovým lepidlom (mat gtv 1x(4,8 cmx4,8 cm) (blis.Al))5.6.2019Z

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To